These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2291865)

  • 1. D-penicillamine and D-penicillamine-protein disulphide in plasma and synovial fluid of patients with rheumatoid arthritis.
    Joyce DA; Day RO
    Br J Clin Pharmacol; 1990 Oct; 30(4):511-7. PubMed ID: 2291865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics of albumin conjugates of D-penicillamine in humans.
    Joyce DA; Day RO; Murphy BR
    Drug Metab Dispos; 1991; 19(2):309-11. PubMed ID: 1676628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assay for D-penicillamine-protein conjugate in human plasma utilising chemical reduction followed by high-performance liquid chromatography with gold/mercury electrochemical detection.
    Joyce DA; Wade DN
    J Chromatogr; 1988 Sep; 430(2):319-27. PubMed ID: 3235506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics of albumin conjugates of D-penicillamine in rats.
    Joyce DA; Wade DN; Swanson BR
    Drug Metab Dispos; 1989; 17(2):208-11. PubMed ID: 2565212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma and synovial fluid kinetics of flurbiprofen in rheumatoid arthritis.
    Aarons L; Salisbury R; Alam-Siddiqi M; Taylor L; Grennan DM
    Br J Clin Pharmacol; 1986 Feb; 21(2):155-63. PubMed ID: 3954931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of the major metabolites of D-penicillamine in patients with rheumatoid arthritis.
    Carruthers G; Harth M; Freeman D; Weir D; Rothwell R; Butler M
    Clin Invest Med; 1984; 7(1):35-40. PubMed ID: 6723122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D-penicillamine metabolism: the role of transformation in blood plasma.
    Joyce DA; Murphy BR
    Agents Actions; 1990 Nov; 31(3-4):353-7. PubMed ID: 2085148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D-penicillamine metabolism in an in-vivo model of inflamed synovium.
    Joyce DA; Forrest MJ; Brooks PM
    Agents Actions; 1988 Dec; 25(3-4):336-43. PubMed ID: 3218609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of lumiracoxib in plasma and synovial fluid.
    Scott G; Rordorf C; Reynolds C; Kalbag J; Looby M; Milosavljev S; Weaver M; Huff JP; Ruff DA
    Clin Pharmacokinet; 2004; 43(7):467-78. PubMed ID: 15139795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased binding of D-penicillamine to monocytes in rheumatoid arthritis.
    Watanabe H; Grimsley G; Major GA; Dawkins RL
    Clin Immunol Immunopathol; 1986 Apr; 39(1):173-8. PubMed ID: 3948434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disappearance kinetics of solutes from synovial fluid after intra-articular injection.
    Owen SG; Francis HW; Roberts MS
    Br J Clin Pharmacol; 1994 Oct; 38(4):349-55. PubMed ID: 7833225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacokinetics of the enantiomers of flurbiprofen in patients with rheumatoid arthritis.
    Young MA; Aarons L; Toon S
    Br J Clin Pharmacol; 1991 Jan; 31(1):102-4. PubMed ID: 2015160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mode of action of D-penicillamine in chronic polyarthritis. 1. Protein synthesis inhibition in synovial fluid cells].
    Bröll H; Altmann H; Kocsis R; Tausch G
    Z Rheumatol; 1978; 37(1-2):51-5. PubMed ID: 629096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synovial fluid and plasma kinetics of repeat dose sustained action tiaprofenic acid in patients with rheumatoid arthritis.
    Nichol FE; Samanta A; Rose CM
    Drugs; 1988; 35 Suppl 1():46-51. PubMed ID: 3359945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methods for assaying D-penicillamine in a clinical setting.
    Crawhall JC
    Clin Invest Med; 1984; 7(1):31-4. PubMed ID: 6723121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of D-penicillamine in patients with rheumatoid arthritis undergoing hemodialysis.
    Matthey F; Perrett D; Greenwood RN; Baker LR
    Clin Nephrol; 1986 May; 25(5):268-71. PubMed ID: 3720037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of piroxicam to synovial fluid and plasma proteins in patients with rheumatoid arthritis.
    Trnavská Z; Trnavský K; Zlnay D
    Eur J Clin Pharmacol; 1984; 26(4):457-61. PubMed ID: 6734706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of salicylate binding to synovial fluid and plasma protein in patients with rheumatoid arthritis.
    Trnavská Z; Trnavský K
    Eur J Clin Pharmacol; 1980 Nov; 18(5):403-6. PubMed ID: 7439262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The penetration of ceftriaxone into synovial fluid of the inflamed joint.
    Morgan JR; Paull A; O'Sullivan M; Williams BD
    J Antimicrob Chemother; 1985 Sep; 16(3):367-71. PubMed ID: 4055544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of serum and synovial fluid concentrations of beta 2-microglobulin and C reactive protein in relation to clinical disease activity and synovial inflammation in rheumatoid arthritis.
    Walters MT; Stevenson FK; Goswami R; Smith JL; Cawley MI
    Ann Rheum Dis; 1989 Nov; 48(11):905-11. PubMed ID: 2512862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.